Abstract
Fundamental studies of cystic fibrosis and the importance of their implementation in clinical practice Yuriy I. Feshchenko, Maryna O. Polyanska, Svitlana G. Opimakh State Institution «National Scientific Center of Phthisiatry, Pulmonology and Allergology named after F. G. Yanovsky of the National Academy of Medical Sciences of Ukraine», 10 M. Amosova Str., Kyiv 01038, Ukraine Introduction. Cystic fibrosis (CF) is a genetic (hereditary) disease caused by mutations in the gene encoding the synthesis of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. A hundred years ago, most babies with this pathology did not live to 18 months. Today, the average survival age of a child born with CF is about 50 years. The aim: to study the fundamental researches of CF and the significance of their implementation in clinical practice. Materials and methods. A search of sources was conducted in the scientific databases of Elsevier, PubMed® and Google Scholar using the keywords «mucoviscidosis» or «cystic fibrosis» and «study history», «fundamental research», «life expectancy» in Ukrainian and English language publications. 61 literary sources were selected for in-depth analysis. Results. The history of CF is ancient dating back thousands of years. «Cystic fibrosis of the pancreas» was first described as an independent disorder in 1938. The autosomal recessive inheritance pattern for CF was established in 1946. The pilocarpine sweat test was developed in 1959 – a diagnostic test that is still used today. In 1979, thanks to the invention of the serum immunoreactive trypsinogen assay laid the foundation for the development of a population-based early newborn screening program. In 1989, the was made gene was identified, opening new research avenues for both diagnosis and treatment. Since then, it has been possible to establish a diagnosis by direct identification of two mutant alleles of CFTR. A breakthrough in the treatment of CF was made possible by the discovery of CFTR modulators, as they can be used to improve or potentially correct CFTR function and other associated complications. A breakthrough in the treatment of CF was made possible with the discovery of CFTR modulators, as they can be used to improve or potentially correct CFTR function and other associated complications. Conclusions. Cystic fibrosis is an example of a successful interaction between science and practice, when theoretical discoveries have been translated into the clinic with overwhelmingly positive results for patients. It is a rare disease that has become a leader in transformative molecular therapy. The promise of gentic therapy and gene editing approaches to restore CFTR function in the lungs offers unprecedented opportunities to transform CF from a fatal disease to a treatable and potentially curable one. Keywords: cystic fibrosis, cystic fibrosis transmembrane conductance regulator (CFTR) gene, sweat test, CFTR modulators, fundamental research.